Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus (Q37590325)

21 August 2017

1 reference

title

Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus (English)

1 reference

21 August 2017

0 references

1 reference

Shuhei Sakakibara

1

1 reference

PubMed ID

19722843

21 August 2017

Giovanna Tosato

series ordinal

2

1 reference

21 August 2017

1 September 2009

1 reference

21 August 2017

15

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

21 August 2017

4

1 reference

21 August 2017

903-917

1 reference

21 August 2017

7

1 reference

Angiogenesis as a therapeutic target

21 August 2017

1 reference

Angiogenesis in nodal B cell lymphomas: a high throughput study.

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

The biology of VEGF and its receptors

21 January 2018

1 reference

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

VEGF inhibition: insights from preclinical and clinical studies

21 January 2018

1 reference

Antiangiogenesis to treat cancer and intraocular neovascular disorders

21 January 2018

1 reference

Angiogenesis in health and disease

21 January 2018

1 reference

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

21 January 2018

1 reference

Molecular regulation of vessel maturation

21 January 2018

1 reference

Poxvirus homologues of cellular genes

21 January 2018

1 reference

The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus

21 January 2018

1 reference

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

21 January 2018

1 reference

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

EBV persistence in memory B cells in vivo.

21 January 2018

1 reference

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo

21 January 2018

1 reference

Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients

21 January 2018

1 reference

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

21 January 2018

1 reference

Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx

21 January 2018

1 reference

Histopathology of nasopharyngeal carcinoma.Correlations with epidemiology, survival rates and other biological characteristics

21 January 2018

1 reference

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.

21 January 2018

1 reference

Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth

21 January 2018

1 reference

The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.

21 January 2018

1 reference

TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1

21 January 2018

1 reference

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

21 January 2018

1 reference

LMP1 TRAFficking activates growth and survival pathways

21 January 2018

1 reference

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

21 January 2018

1 reference

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.

21 January 2018

1 reference

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

21 January 2018

1 reference

Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein

21 January 2018

1 reference

An Epstein-Barr virus protein interacts with Notch

21 January 2018

1 reference

Modulation of LMP1 protein expression by EBV-encoded microRNAs

21 January 2018

1 reference

Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen

21 January 2018

1 reference

A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

21 January 2018

1 reference

Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing

21 January 2018

1 reference

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

21 January 2018

1 reference

KSHV vFLIP binds to IKK-gamma to activate IKK.

21 January 2018

1 reference

The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.

21 January 2018

1 reference

Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs

21 January 2018

1 reference

A viral microRNA functions as an orthologue of cellular miR-155

21 January 2018

1 reference

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

21 January 2018

1 reference

Anti-tumor effect of angiogenesis inhibitor TNP-470 on the human nasopharyngeal carcinoma cell line NPC/HK1.

21 January 2018

1 reference

Helicobacter pylori infection and the risk of gastric carcinoma

21 January 2018

1 reference

Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.

21 January 2018

1 reference

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

21 January 2018

1 reference

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

21 January 2018

1 reference

Anti-angiogenic treatment of gastrointestinal malignancies

21 January 2018

1 reference

Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues

21 January 2018

1 reference

VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites

21 January 2018

1 reference

Molecular biology and pathology of lymphangiogenesis

21 January 2018

1 reference

Lymphangiogenesis in gastric carcinoma correlates with prognosis.

21 January 2018

1 reference

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

21 January 2018

1 reference

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

21 January 2018

1 reference

Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia

21 January 2018

1 reference

Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity

21 January 2018

1 reference

Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production

21 January 2018

1 reference

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity

21 January 2018

1 reference

A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

21 January 2018

1 reference

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

Unique signaling properties of CTAR1 in LMP1-mediated transformation

21 January 2018

1 reference

Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

21 January 2018

1 reference

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking

21 January 2018

1 reference

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

21 January 2018

1 reference

Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence

21 January 2018

1 reference

beta-catenin signaling and cancer

21 January 2018

1 reference

Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development

21 January 2018

1 reference

An auto-regulatory loop for EBV LMP2A involves activation of Notch

21 January 2018

1 reference

Notch signaling in vascular development

21 January 2018

1 reference

Notch signaling in primary endothelial cells

21 January 2018

1 reference

Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium

21 January 2018

1 reference

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

21 January 2018

1 reference

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

21 January 2018

1 reference

Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition

21 January 2018

1 reference

A perivascular origin for mesenchymal stem cells in multiple human organs

21 January 2018

1 reference

T-cell transformation and oncogenesis by gamma2-herpesviruses

21 January 2018

1 reference

Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype

21 January 2018

1 reference

Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation

21 January 2018

1 reference

Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells

21 January 2018

1 reference

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

21 January 2018

1 reference

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo

21 January 2018

1 reference

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

21 January 2018

1 reference

The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors.

21 January 2018

1 reference

Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene

21 January 2018

1 reference

The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion

21 January 2018

1 reference

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression

21 January 2018

1 reference

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

21 January 2018

1 reference

Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

21 January 2018

1 reference

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

21 January 2018

1 reference

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

21 January 2018

1 reference

Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.

21 January 2018

1 reference

Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.

21 January 2018

1 reference

Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program

21 January 2018

1 reference

Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

21 January 2018

1 reference

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

21 January 2018

1 reference

The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage

21 January 2018

1 reference

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

21 January 2018

Fibroblasts in cancer

1 reference

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.09.49

1 reference

release_v5o3afxhdbc2zgpoi27kpxpjze

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v5o3afxhdbc2zgpoi27kpxpjze

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19722843

1 reference

PubMed ID

19722843